Antidepressants

Healthplan Pharma (India) Pvt. Ltd. Delhi and Jaipur offers a comprehensive and clinically relevant range of antidepressant formulations designed to support the treatment of depressive disorders, anxiety disorders, and associated psychiatric conditions. The portfolio spans multiple therapeutic classes, providing healthcare professionals with flexibility to individualize treatment based on patient symptoms, severity, and tolerability.

Our antidepressant range includes monotherapies and fixed-dose combinations, available in multiple strengths and dosage forms to support both initiation and maintenance therapy.

Imipramine-Based Formulations

Meridep® 75

Tablets
(Imipramine 75 mg)

Meridep® 2

Tablets
(Imipramine 25 mg + Diazepam 2 mg)

Escitalopram-Based Formulations

Holotil® 10

Tablets
(Escitalopram 10 mg)

Holotil® Plus

Tablets
(Escitalopram 10 mg + Clonazepam 0.5 mg)

Fluoxetine Formulation

Holonet® 20

Capsules
(Fluoxetine 20 mg)

Amitriptyline-Based Formulations

Meriline® 10/25

Tablets
(Amitriptyline 10 mg / 25 mg)

Meriline® H

Tablets
(Amitriptyline 12.5 mg + Chlordiazepoxide 5 mg)

Meriline® Plus

Tablets
(Amitriptyline 25 mg + Chlordiazepoxide 10 mg)

Duloxetine Formulation

Doloplan® 20/30

Tablets
(Duloxetine 20 mg / 30 mg)

Mirtazapine Formulation

Meeta® 15/30

Tablets
(Mirtazapine 15 mg / 30 mg)

Paroxetine Controlled-Release Formulation

Xodep® CR 12.5/25

Tablets
(Paroxetine CR 12.5 mg / 25 mg)

Fluvoxamine Formulation

Floxa® 50/100

Tablets
(Fluvoxamine Maleate 50 mg / 100 mg)